Home | Help Center

Endless possibilities in academia

ISSN: 2957-5443
Indexed in: Europub, Crossref, Dimensions, Google Scholar
Editor-in-Chief: Lize XIONG
Submit Review
Volume 1, Issue 1
Progress of end-tidal carbon dioxide monitoring in non-intubated patients

Review Article |Published on: 30 June 2023

[Perioperative Precision Medicine] 2023; 1 (1): 15-23.

DOI: https://doi.org/10.61189/343605tjncke
PDF
CITE
The interaction of Candida albicans with C-type lectin receptors

Lindong Cheng1, Ping Li2, Duy Khanh La3,4, Zhen Xing5,#, Chunhua Liao6,# 


1Graduate School, Hebei North University, Hebei 075000, China. 2Graduate School, Wannan Medical College, Anhui 241000, China. 3Foreign Training Group, Naval Military Medical University, Shanghai 200433, China. 4Faculty of Medicine, Vietnam Military Medical University, Hanoi 100000, Vietnam. 5Department of Anesthesiology, the First Affiliated Hospital of Hebei North University, Hebei 075000, China. 6School of Anesthesiology, Second Military Medical University/Naval Medical University, Shanghai 200433, China. 

 

 #Address correspondence to: Chunhua Liao, School of Anesthesiology, Second Military Medical University/Naval Medical University, Shanghai 200433, China. E-mail: liaochh7@smmu.edu.cn; Zhen Xing, Department of Anesthesiology, the First Affiliated Hospital of Hebei North University, Hebei 075000, China. E-mail: xingzhen@sina.com.


Received March 19, 2023; Accepted May 16, 2023; Published June 30, 2023


DOI: https://doi.org/10.61189/863627autews


Highlights

Candidiasis is a substantial cause of perioperative mortality in immunocompromised and immunodeficient patients. 

β-glucan and α-mannan are two major pathogen-associated molecular patterns in the Candida albicans cell walls recognized by C-type lectin receptors (CLRs). 

CLRs, such as Dectin-1 and Dectin-2, as β-glucan and α-mannan receptors, are essentially involved in recogni tion of Candida albicans

CLRs are promising drug targets for treating chronic candidiasis.

Review Article |Published on: 30 June 2023

[Perioperative Precision Medicine] 2023; 1 (1): 24-36.

DOI: https://doi.org/10.61189/863627autews
PDF
CITE
MicroRNAs: Regulators of the host antifungal immune response

Yanchen Lin1, Ping Li2, Jinliang Teng3,#, Chunhua Liao4,# 


1Graduate School, Hebei North University, Hebei 075000, China. 2Graduate School, Wannan Medical College, Anhui 241000, China. 3Department of Anesthesiology, the First Affiliated Hospital of Hebei North University, Hebei 075000, China. 4School of Anesthesiology, Second Military Medical University/Naval Medical University, Shanghai 200433, China.


#Address correspondence to: Chunhua Liao, School of Anesthesiology, Second Military Medical University/Naval Medical University, Shanghai, 200433, China. E-mail: liaochh7@smmu.edu.cn; Jinliang Teng, Department of Anesthesiology, the First Affiliated Hospital of Hebei North University, Hebei 075000, China. E-mail: tengjinliang@126. com.


Received April 6, 2023; Accepted May 18, 2023; Published June 30, 2023


DOI: https://doi.org/10.61189/595412fcjdhw


Highlights

Patients are at a high risk of fungal infection during perioperative period. 

MicroRNAs are involved in inflammatory responses, pyroptosis and autophagy in antifungal immunity. 

MicroRNAs modulate the activation of Th cells during fungal infection, thereby regulating the adaptive immune response. 

Differentially expressed miRNAs could be used as fungal infection biomarkers.

Review Article |Published on: 30 June 2023

[Perioperative Precision Medicine] 2023; 1 (1): 37-47.

DOI: https://doi.org/10.61189/595412fcjdhw
PDF
CITE